Headquartered in Tarrytown, NY Fiscal year ends March NYSE: PBH prestigebrands.com
Prestige Consumer Healthcare Inc. (NYSE: PBH) markets, sells, manufactures, and distributes over-the-counter consumer healthcare products through retail outlets in the U.S., Canada, Australia, and select international markets. The company operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio spans multiple categories including gastrointestinal (Fleet, Gaviscon in Canada), dermatological/skin care (Compound W, Boudreaux's Butt Paste, Dermal Therapy in Australia), women's health (Monistat, Summer's Eve), eye and ear care (Clear Eyes, TheraTears, Debrox), oral care (DenTek), analgesics (BC, Goody's), cough/cold/allergy (Chloraseptic, Luden's), motion sickness (Dramamine), pediatric care (Little Remedies), lice treatment (Nix), rehydration (Hydralyte in Australia), and wellness/better-breathing (Breathe Right nasal strips). The company recently expanded its portfolio through the acquisitions of the Breathe Right brand portfolio from a major multinational and LaCorium Health (Dermal Therapy brand), adding approximately $240 million in expected annual revenue and entering the better-breathing wellness category. Prestige also owns and operates the Pillar5 sterile manufacturing facility, which it is investing in to build long-term eye care production capacity. Updated
Monday's top analyst upgrades and downgrades included Alibaba, Analog Devices, Caterpillar, Cloudflare, Coinbase Global, DraftKings, JPMorgan Chase, Marriott International, Rivian Automotive, Toast, Twilio and Walmart.
The top analyst upgrades, downgrades and other research calls from Monday include Amgen, Boeing, Chevron, Exxon Mobil, Foot Locker, Lowe's, Nokia, PayPal, Sprint and Wells Fargo.
The top analyst upgrades, downgrades and other research calls from Monday include Blue Apron, Broadcom, Charter Communications, CVS Health, Delphi, eBay, Rite Aid and UPS.
The top analyst upgrades, downgrades and other research calls seen on Monday include Blackstone, Ciena, Cree, Finish Line, Motorola Solutions and Qualcomm.
The top analyst upgrades, downgrades and initiations seen on Friday, February 5, include Coca-Cola, Goldman Sachs, JPMorgan, LinkedIn, Linn Energy, Tableau Software and Weatherford International.
Monday's top analyst upgrades, downgrades and initiations include Fitbit, GE, Lockheed Martin, Lululemon Ahtletica, Marriott, Microsoft, Philip Morris and SLM.
This Tuesday's top analyst upgrades, downgrades and initiations include AK Steel, Alcoa, Electronic Arts, Intel, IBM, Sony, Tyco International and Wells Fargo.
Most Wall St. firms are divided by the unit that calls on the retail or high net worth client, and the unit that calls on institutional clients. They both generally benefit from…
Jon OggThese are some of this Thursday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. CenturyLink Inc. (NYSE: CTL) cut to Neutral at J.P. Morgan, cut to Reduce…
Jon OggThese are the top analyst calls of upgrades, downgrades and initiations we have seen from Wall St. research calls this Wednesday morning. Angie’s List Inc. (NASDAQ: ANGI) raised to Outperform at…
US equity markets opened sharply higher this morning and have been able to sustain and even add to those gains throughout the day. Business and consumer confidence indexes in Europe were higher,…
These are some of the top early bird upgrades and downgrades we have seen from Wall Street analysts this Monday morning: Agilent (NYSE: A) Raised to Outperform at Baird. Gentex (NASDAQ: GNTX)…
Some of these stocks hit 52-week lows and recovered off of lows so they won’t have a low close. But these did all touch or breach the 52-week lows. At the end…
Prestige Consumer Healthcare Inc. (NYSE: PBH) markets, sells, manufactures, and distributes over-the-counter consumer healthcare products through retail outlets in the U.S., Canada, Australia, and select international markets.
24/7 Wall St.'s 12-month price target for PBH is $63.24, rated Buy. The Wall Street consensus target is $67.80. PBH price prediction →
